These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8569576

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mycobacterium ulcerans infections in two horses in south-eastern Australia.
    van Zyl A, Daniel J, Wayne J, McCowan C, Malik R, Jelfs P, Lavender CJ, Fyfe JA.
    Aust Vet J; 2010 Mar; 88(3):101-6. PubMed ID: 20402694
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mycobacterium ulcerans disease.
    van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, Fleischer B, Wansbrough-Jones MH, Johnson PD, Portaels F, van der Graaf WT, Asiedu K.
    Bull World Health Organ; 2005 Oct; 83(10):785-91. PubMed ID: 16283056
    [Abstract] [Full Text] [Related]

  • 28. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples.
    Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, Azuolas J, Stinear TP.
    Appl Environ Microbiol; 2007 Aug; 73(15):4733-40. PubMed ID: 17526786
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.
    Phillips R, Horsfield C, Kuijper S, Sarfo SF, Obeng-Baah J, Etuaful S, Nyamekye B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk AH, Wansbrough-Jones M.
    Clin Vaccine Immunol; 2006 Feb; 13(2):253-7. PubMed ID: 16467334
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.
    Phillips R, Adjei O, Lucas S, Benjamin N, Wansbrough-Jones M.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2866-70. PubMed ID: 15273093
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
    Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, King CH, Tappero JW, Ashford DA.
    Clin Infect Dis; 2005 May 15; 40(10):1445-53. PubMed ID: 15844067
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Buruli ulcer. Mycobacterium ulcerans infection.
    Wkly Epidemiol Rec; 2002 May 17; 77(20):165-6. PubMed ID: 12040740
    [No Abstract] [Full Text] [Related]

  • 39. Mycobacterium ulcerans treatment costs, Australia.
    Drummond C, Butler JR.
    Emerg Infect Dis; 2004 Jun 17; 10(6):1038-43. PubMed ID: 15207055
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.